Pierre Bischoff

1.2k total citations
39 papers, 1.0k citations indexed

About

Pierre Bischoff is a scholar working on Molecular Biology, Oncology and Epidemiology. According to data from OpenAlex, Pierre Bischoff has authored 39 papers receiving a total of 1.0k indexed citations (citations by other indexed papers that have themselves been cited), including 20 papers in Molecular Biology, 10 papers in Oncology and 8 papers in Epidemiology. Recurrent topics in Pierre Bischoff's work include Autophagy in Disease and Therapy (6 papers), Radiation Therapy and Dosimetry (5 papers) and Cholesterol and Lipid Metabolism (4 papers). Pierre Bischoff is often cited by papers focused on Autophagy in Disease and Therapy (6 papers), Radiation Therapy and Dosimetry (5 papers) and Cholesterol and Lipid Metabolism (4 papers). Pierre Bischoff collaborates with scholars based in France, Belgium and United States. Pierre Bischoff's co-authors include Francis J. Dumont, Vincent Holl, Jean‐Pierre Bergerat, P. Dufour, John Gueulette, Jean‐Philippe Loeffler, Christian Gaiddon, Michel Pfeffer, Claude B. Sirlin and Jean‐Marc Denis and has published in prestigious journals such as Journal of the American College of Cardiology, Cancer Research and Biochemical Journal.

In The Last Decade

Pierre Bischoff

39 papers receiving 987 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Pierre Bischoff France 19 455 336 220 131 122 39 1.0k
Francisco Javier Rodrı́guez-Berrocal Spain 22 677 1.5× 442 1.3× 109 0.5× 64 0.5× 203 1.7× 61 1.4k
F. Zunino Italy 19 565 1.2× 514 1.5× 119 0.5× 94 0.7× 123 1.0× 33 1.2k
Kendra D. Tutsch United States 19 773 1.7× 502 1.5× 93 0.4× 79 0.6× 207 1.7× 39 1.5k
Bruce Gomes United States 16 834 1.8× 267 0.8× 261 1.2× 67 0.5× 173 1.4× 17 1.3k
Anthea Hardcastle United Kingdom 19 710 1.6× 410 1.2× 106 0.5× 127 1.0× 110 0.9× 38 1.3k
Mitsuaki Watanabe Japan 20 296 0.7× 430 1.3× 446 2.0× 58 0.4× 98 0.8× 84 1.6k
David Austin United Kingdom 19 774 1.7× 244 0.7× 280 1.3× 84 0.6× 54 0.4× 77 1.6k
Satish K. Chitneni United States 16 365 0.8× 179 0.5× 125 0.6× 100 0.8× 190 1.6× 42 880
Gunhild von Amsberg Germany 22 480 1.1× 309 0.9× 205 0.9× 87 0.7× 277 2.3× 115 1.5k
J. Liebmann United States 14 324 0.7× 548 1.6× 69 0.3× 67 0.5× 134 1.1× 19 1.2k

Countries citing papers authored by Pierre Bischoff

Since Specialization
Citations

This map shows the geographic impact of Pierre Bischoff's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Pierre Bischoff with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Pierre Bischoff more than expected).

Fields of papers citing papers by Pierre Bischoff

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Pierre Bischoff. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Pierre Bischoff. The network helps show where Pierre Bischoff may publish in the future.

Co-authorship network of co-authors of Pierre Bischoff

This figure shows the co-authorship network connecting the top 25 collaborators of Pierre Bischoff. A scholar is included among the top collaborators of Pierre Bischoff based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Pierre Bischoff. Pierre Bischoff is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Burckel, Hélène, Elodie Josset, Jean‐Marc Denis, et al.. (2014). Combination of the mTOR inhibitor RAD001 with temozolomide and radiation effectively inhibits the growth of glioblastoma cells in culture. Oncology Reports. 33(1). 471–477. 6 indexed citations
2.
Josset, Elodie, Jean‐Marc Denis, John Gueulette, et al.. (2012). The mTOR inhibitor RAD001 augments radiation-induced growth inhibition in a hepatocellular carcinoma cell line by increasing autophagy. International Journal of Oncology. 41(4). 1381–1386. 26 indexed citations
3.
Dumont, Francis J. & Pierre Bischoff. (2012). Disrupting the mTOR Signaling Network as a Potential Strategy for the Enhancement of Cancer Radiotherapy. Current Cancer Drug Targets. 12(8). 899–924. 27 indexed citations
4.
Bischoff, Pierre, Elodie Josset, & Francis J. Dumont. (2012). Novel pharmacological modulators of autophagy and therapeutic prospects. Expert Opinion on Therapeutic Patents. 22(9). 1053–1079. 14 indexed citations
5.
Meng, Xiangjun, Marjorie Jenny, Isabelle Groß, et al.. (2009). A Ruthenium-Containing Organometallic Compound Reduces Tumor Growth through Induction of the Endoplasmic Reticulum Stress Gene CHOP. Cancer Research. 69(13). 5458–5466. 190 indexed citations
6.
Dumont, Francis J., et al.. (2009). Radiosensitising agents for the radiotherapy of cancer: novel molecularly targeted approaches. Expert Opinion on Therapeutic Patents. 19(6). 775–799. 19 indexed citations
7.
Dumont, Francis J., et al.. (2009). Radiation countermeasure agents: an update. Expert Opinion on Therapeutic Patents. 20(1). 73–101. 62 indexed citations
8.
Benzina, Sami, et al.. (2008). High-LET radiation combined with oxaliplatin induce autophagy in U-87 glioblastoma cells. Cancer Letters. 264(1). 63–70. 27 indexed citations
9.
Benzina, Sami, Jean‐Pierre Bergerat, Jean‐Marc Denis, et al.. (2007). The cytotoxicity of high-linear energy transfer radiation is reinforced by oxaliplatin in human glioblastoma cells. Cancer Letters. 254(1). 54–62. 7 indexed citations
10.
Benzina, Sami, Barbara Fischer, P. Dufour, et al.. (2006). Cell death induced in a human glioblastoma cell line by p(65)+Be neutrons combined with cisplatin. Life Sciences. 79(6). 513–518. 10 indexed citations
11.
Fischer, Barbara, Sami Benzina, P. Dufour, et al.. (2005). Fast neutrons-induced apoptosis is Fas-independent in lymphoblastoid cells. Biochemical and Biophysical Research Communications. 334(2). 533–542. 5 indexed citations
12.
Schneider, Yann, Barbara Fischer, David Coelho, et al.. (2004). (Z)-3,5,4′-Tri-O-methyl-resveratrol, induces apoptosis in human lymphoblastoid cells independently of their p53 status. Cancer Letters. 211(2). 155–161. 9 indexed citations
13.
Bischoff, Pierre, et al.. (2004). Synthesis and photocytotoxic activity of new α-methylene-γ-butyrolactone-psoralen heterodimers. Bioorganic & Medicinal Chemistry. 12(13). 3619–3625. 12 indexed citations
14.
Bischoff, Pierre, et al.. (2003). Signal Transduction Pathways of Taxanes-Induced Apoptosis. PubMed. 3(4). 291–306. 113 indexed citations
15.
Fischer, Barbara, et al.. (2003). Caspase 8-mediated cleavage of the pro-apoptotic BCL-2 family member BID in p53-dependent apoptosis. Biochemical and Biophysical Research Communications. 306(2). 516–522. 36 indexed citations
16.
Holl, Vincent, et al.. (2000). Prevention of nitrogen mustard-induced apoptosis in normal and transformed lymphocytes by ebselen. Biochemical Pharmacology. 60(11). 1565–1577. 19 indexed citations
17.
Bischoff, Pierre, Vincent Holl, David Coelho, et al.. (2000). Apoptosis at the Interface of Immunosuppressive and Anticancer Activities: The Examples of Two Classes of Chemical Inducers, Oxysterols and Alkylating Agents. Current Medicinal Chemistry. 7(7). 693–713. 25 indexed citations
18.
Gény, Bernard, Bertrand Mettauer, Pierre Bischoff, et al.. (1993). Safety and efficacy of a new transpulmonary echo contrast agent in echocardiographic studies in patients. Journal of the American College of Cardiology. 22(4). 1193–1198. 59 indexed citations
19.
Moog, Christiane, Bang Luu, Anne Altmeyer, & Pierre Bischoff. (1989). Studies on the immunosuppressive properties of 7,25 dihydroxycholesterol-II. Effects on early steps of T-cell activation. International Journal of Immunopharmacology. 11(5). 559–565. 20 indexed citations
20.
Altmeyer, Anne, Christiane Moog, Caroline Waltzinger, G. Hauptmann, & Pierre Bischoff. (1989). In vitro modulation of leucocyte-function-associated antigen-1 expression on two leukemic cell lines. Cancer Immunology Immunotherapy. 29(1). 29–34. 3 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Francisco Javier Rodrı́guez-Berrocal Breakdown of academic impact, for papers by F. Zunino Breakdown of academic impact, for papers by Kendra D. Tutsch Breakdown of academic impact, for papers by Bruce Gomes Breakdown of academic impact, for papers by Anthea Hardcastle Breakdown of academic impact, for papers by Mitsuaki Watanabe Breakdown of academic impact, for papers by David Austin Breakdown of academic impact, for papers by Satish K. Chitneni Breakdown of academic impact, for papers by Gunhild von Amsberg Breakdown of academic impact, for papers by J. Liebmann
Rankless by CCL
2026